Gene · 344
Papers3,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review. | Cardiovasc Diabetol | 2022 | 36471375 | PubTator, text mining | PubMed |
| Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery. | Clin Sci (Lond) | 2022 | 36459456 | PubTator, text mining | PubMed |
| An investigation of codon usage pattern analysis in pancreatitis associated genes. | BMC Genom Data | 2022 | 36434531 | PubTator, text mining | PubMed |
| The Effects of Barbed Repositioning Pharyngoplasty in Positional and Non-Positional OSA Patients: A Retrospective Analysis. | J Clin Med | 2022 | 36431226 | PubTator, text mining | PubMed |
| Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism. | Int J Mol Sci | 2022 | 36430456 | PubTator, text mining | PubMed |
| Clinical heterogeneity in monogenic chylomicronaemia. | BMJ Case Rep | 2022 | 36423940 | PubTator, text mining | PubMed |
| Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. | Cancer Cell | 2022 | 36423636 | PubTator, text mining | PubMed |
| Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies. | Biol Sex Differ | 2022 | 36414996 | PubTator, text mining | PubMed |
| APOE alleles modulate associations of plasma metabolites with variants from multiple genes on chromosome 19q13.3. | Front Aging Neurosci | 2022 | 36389057 | PubTator, text mining | PubMed |
| First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency. | Heliyon | 2022 | 36387451 | PubTator, text mining | PubMed |
| Advances in multi-omics study of biomarkers of glycolipid metabolism disorder. | Comput Struct Biotechnol J | 2022 | 36382190 | PubTator, text mining | PubMed |
| Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies. | Neurooncol Adv | 2022 | 36382110 | PubTator, text mining | PubMed |
Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan. | BMJ Open | 2022 | 36375977 | PubTator, text mining | PubMed |
| ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis. | Curr Atheroscler Rep | 2022 | 36367663 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models. | Int J Mol Sci | 2022 | 36362217 | PubTator, text mining | PubMed |
| Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease. | Children (Basel) | 2022 | 36360378 | PubTator, text mining | PubMed |
| Bile Acids in Intrahepatic Cholestasis of Pregnancy. | Diagnostics (Basel) | 2022 | 36359589 | PubTator, text mining | PubMed |
| Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia. | Biomedicines | 2022 | 36359273 | PubTator, text mining | PubMed |
| LRRK2 and Lipid Pathways: Implications for Parkinson's Disease. | Biomolecules | 2022 | 36358947 | PubTator, text mining | PubMed |
| Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia. | Sci Rep | 2022 | 36351970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/344/papers?page=20